COVID-19 Pandemic: National Rapid Guidance

2020

People who use substances, service providers, and decision makers

At the request of the Government of Canada, CRISM rapidly developed a series of six national guidance documents. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID‑19 pandemic.

Guidelines

Supporting people who use substances in shelter settings during the COVID-19 pandemic

Telemedicine support for addiction services

Supporting people who use substances in acute care settings during the COVID-19 pandemic

Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic

Strategies to reduce SARS-CoV-2 transmission in supportive recovery programs and residential addiction treatment services

Harm reduction worker safety during the COVID-19 global pandemic

Podcast

 In addition to the guidance documents, the Quebec and Atlantic CRISM teams hosted a conversation with Natasha Touesnard, from the Canadian Association of People who Use Drugs (CAPUD), and Dr. Selene Etches, on the Telemedicine Support for Addiction Services National Rapid Guidance document.

Webinars

CRISM also conducted a webinar with Health Canada to highlight the main findings from the COVID-19 Rapid Guidance Documents and Related Projects.

Program Overview

  • English Feb 5, 2021


Supporting people who use substances in shelter settings during the COVID-19 pandemic

  • English June 14, 2021


Supporting people who use substances in acute care settings during the COVID-19 pandemic

  • English June 21, 2021

Feedback

To provide feedback on the guidance documents, please use the links below. You may select the feedback form in either French or English.
Verified by ExactMetrics